Akorn — Corporate Update (July 2020)
21 slides from Akorn's corporate update, Jul 2, 2020
Slide 1: Updated 2020 Forecast June 2020
Updated 2020 Forecast June 2020
Slide 2: Disclaimer
Disclaimer By reading or reviewing the presentation slides, you agree to be bound by the following limitations. This presentation has been prepared for informational and background purposes only and the information contained herein (unle ss otherwise indicated) has been provided by Akorn, Inc. (toge
Slide 3: Disclaimer (Continued)
Disclaimer (Continued) This presentation includes statements that may constitute “forward - looking statements,” including statements regarding the effects of COVID - 19, as well as expected product launches, plant spending, cash flow, revenue, the Company's long - term business plan and outlook, th
Slide 4: Disclaimer (Continued)
Disclaimer (Continued) This presentation may include information from the S&P Capital IQ Platform Service. Such information is subject to the follow ing : “Copyright © 2020, S&P Capital IQ (and its affiliates, as applicable). This may contain information obtained from third parties, including rating
Slide 5: Important Information
Important Information By accepting this presentation, the recipient agrees to use the information herein in accordance with its compliance policies , c ontractual obligations (including, but not limited to, the provisions of that certain confidentiality agreement entered into between the recipient a
Slide 6: Table of Contents
Table of Contents • Updated 2020 Forecast • Appendix: Monthly Support Schedules • Appendix: GAAP to Adjusted Reconciliations 6
Slide 7: Key Drivers of 2020 Performance and Outlook
Key Drivers of 2020 Performance and Outlook 7 Recent Performance Update • COVID - 19 severely impacted our performance beginning in Q2 as demand for our products was reduced by fewer hospital visits and restricted patient access to ophthalmology and optometrist practices. o For the overall portfolio
Slide 8: Updated 2020 Forecast
Updated 2020 Forecast • April and May expected to represent the low point regarding COVID - 19 impact with expected recovery throughout the remainder of the year. • Q4 forecast growth includes new product launch and return to pre - COVID business performance. Note: Reconciliations of Gross Margin to
Slide 9: 2020 Quarterly Adjusted EBITDA Bridge: LRP v. Updated Forecast
2020 Quarterly Adjusted EBITDA Bridge: LRP 1 v. Updated Forecast 1. “LRP” refers to the forecast prepared in January 2020 that was included in the Company’s Current Report on Form 8 - K, that was fi led with the SEC on April 22, 2020. 9 • COVID - 19 results in an estimated $36mm reduction of EBITDA
Slide 10: 2020 Adjusted EBITDA to Unlevered Free Cash Flow
2020 Adjusted EBITDA to Unlevered Free Cash Flow 1. Reconciliation of Net (Loss) Income to Adjusted EBITDA appears on page 20 of the Appendix. 2. Forecast excludes income tax payments and refunds. 3. Reconciliations of Net Cash (Used In) Operating Activities to Unlevered Free Cash Flow from Operatio
Slide 11: Top Product Groups – Quarterly Trends
Top 30 Product Groups – Quarterly Trends 1. Estimated product level revenue. 2. Increase in Q1 2020 Net Sales driven by approximately $36 million of net revenue from a sale of remaining inventory of an una ppr oved product that has since been discontinued. 11 Net Sales ($ in millions) 1 FY 2019A Q4
Slide 12: Updated Forecast EBITDA Bridge: Q4 2020 Annualized to 2021
Tie out to 2021F presented in Jan 2020 LRP 1 Updated Forecast EBITDA Bridge: Q4 2020 Annualized to 2021 12 ($ in millions) 1. “LRP” refers to the forecast prepared in January 2020 that was included in the Company’s Current Report on Form 8 - K, that was fi led with the SEC on April 22, 2020. Note: R
Slide 13: 2021 Adjusted P&L Summary
2021 Adjusted P&L Summary 13 • 2021 Adjusted EBITDA forecast results in a significant improvement from 2020. Note: Projections of GAAP measures are not provided for 2021 because such figures are not available on a forward - looking basis a nd reconciliations of projected non - GAAP measures to their
Slide 14: Table of Contents
Table of Contents • Updated 2020 Forecast • Appendix: Monthly Support Schedules • Appendix: GAAP to Adjusted Reconciliations 14
Slide 15: Updated 2020 Monthly Forecast
Updated 2020 Monthly Forecast 15 Note: Reconciliations of Gross Margin to Adjusted Gross Margin, SG&A to Adjusted SG&A, R&D to Adjusted R&D, Operating Income (Lo ss) to Adjusted Operating Income, Net (Loss) Income to Adjusted EBITDA, and Net Cash (Used In) Operating Activities to Unlevered Free Cash
Slide 16: 2020 Monthly Adjusted EBITDA to Unlevered Free Cash Flow
2020 Monthly Adjusted EBITDA to Unlevered Free Cash Flow 16 1. Reconciliation of Net (Loss) Income to Adjusted EBITDA appears on page 20 of the Appendix. 2. Forecast excludes income tax payments and refunds. 3. Reconciliations of Net Cash (Used In) Operating Activities to Unlevered Free Cash Flow fr
Slide 17: Table of Contents
Table of Contents • Updated 2020 Forecast • Appendix: Monthly Support Schedules • Appendix: GAAP to Adjusted Reconciliations 17
Slide 18: GAAP to Adjusted Reconciliations: Gross Margin and Operating Income
GAAP to Adjusted Reconciliations: Gross Margin and Operating Income 18 GAAP Gross Margin to Adjusted Gross Margin GAAP Operating Income to Adjusted Operating Income UNAUDITED ACTUAL FORECAST FY ACTUAL ($ in millions) Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20
Slide 19: GAAP to Adjusted Reconciliations: SG&A and R&D
GAAP to Adjusted Reconciliations: SG&A and R&D 19 GAAP SG&A to Adjusted SG&A GAAP R&D to Adjusted R&D UNAUDITED ACTUAL FORECAST FY ACTUAL ($ in millions) Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 2020 Q1 2020 GAAP SG&A $21 $24 $20 $21 $23 $17 $19 $55 $16 $16
Slide 20: Net Income to Adjusted EBITDA Reconciliation
Net Income to Adjusted EBITDA Reconciliation 20 UNAUDITED ACTUAL FORECAST FY ACTUAL ($ in millions) Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 2020 Q1 2020 Net (Loss) Income (14) 4 (248) (26) (33) (16) (16) (52) (3) 4 4 3 (392) (257) Adjustments to arrive at
Slide 21: Reconciliation of GAAP Net Cash Used In Operating Activities to Unlevered FCF
Reconciliation of GAAP Net Cash (Used In) Operating Activities to Unlevered FCF & Unlevered FCF from Operations 21 UNAUDITED ACTUAL FORECAST FY ACTUAL ($ in millions) Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 2020 Q1 2020 GAAP Net Cash (Used In) Operating Ac